Welcome to the web site of the Laboratory of Medicinal and Molecular electrochemistry which is part of the School of Science and Technology of Nazarbayev University.

A Brief Introduction from Kevin Lam


It is my great pleasure to welcome you to our website.


Our laboratory is currently studying the syntheses of a variety of biologically active molecules with important pharmacological properties. We are particularly interested in Tyrosine Kinase Inhibitors (TKIs). The concise synthesis of such molecules is a challenge that stimulates us to develop new synthetic methodologies that enable the construction of several bonds and/or rings in a single step and control the chiral centers formed in the process. Much to our delight, our first molecules are now receiving patents in the United States.


Although our research is usually presented in several subgroups, such as the development of new and efficient synthetic methodologies or organometallic chemistry, our topics are thoroughly integrated. For example, various chemical syntheses rely upon the development of new and efficient organometallic catalysts or the use of a new method of activation. This close overlap in our research topics has led us to bring our findings all together in a single place.


I hope that you will enjoy visiting our website.


With Best Regards,


Dr. Kevin Lam

Congratulation to Yerlan and Zhaisan for their new article : "Oligogermanes Containing Only Electron-Withdrawing Substituents: Synthesis and Properties"
We would like to welcome our new group members. Dr. David Hayrapetyan, Dr. Vyacheslav Shkepu as well as Mr. Burkitkan Ahbai.
The Ministry of Education and Science of the Republic of Kazakhstan in collaboration with the National Center of Science and Technology awarded a research grant to Dr. Kevin Lam in collaboration with Dr. Richard Kemp from Sandia National Labs (USA) to work on CO2 recycling using cheap and non toxic catalysts.
The University of Vermont Cancer Center - LCCRO Collaborative Research Grant has been awarded to Drs. Emmons, Verschraegen and Lam to work on Pre-Clinical Anti-cancer Studies of Dr. Lam new compounds.